Dr. Michael Morris on Combining and Sequencing Radium-223

Video

In Partnership With:

Michael Morris, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses combining radium-223 with other types of treatment and how to best optimize the use of the drug alone.

Michael Morris, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses combining radium-223 with other types of treatment and how to best optimize the use of the drug alone.

Androgen receptor—directed therapy, chemotherapy, and novel therapeutics could also be combined with radium-223 to improve survival, says Morris. There is currently a study looking at radium-223 and abiraterone.

Work is also still being done to better understand how to administer radium-223 alone, says Morris. Questions still remain regarding how frequently patients should receive radium-223, how long they should take the drug, and at what dose.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD